Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
or Refractory Mantle Cell Lymphoma
.
Show all posts
Showing posts with label
or Refractory Mantle Cell Lymphoma
.
Show all posts
Tuesday, August 18, 2026
U.S. FDA Grants Full Approval of Kite’s Tecartus for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
›
The U.S. Food and Drug Administration (FDA) has granted traditional (full) approval to Kite’s CAR T-cell therapy, Tecartus (brexucabtagene a...
›
Home
View web version
